$RNST

Engel Connie L sold $51K of RNST

Engel Connie L sold 1,257 shares of RENASANT CORP (RNST) at $40.90 on 2026-05-29.

Original reporting
SEC EDGAR · Engel Connie L
Published Jun 9, 2026, 9:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 9:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RNST
Neutral
high confidence
Mentioned
$RNST
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RNSTNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (shares, price, total value, post-transaction holdings).

02

Market read

Traders may note the insider sale, but there is no accompanying operational, financial, or regulatory catalyst in the text.

03

What to watch

No 10b5-1 plan is cited, but the filing still lacks context (taxes, diversification, personal liquidity), limiting interpretability.

Relevance 3/10Novelty 2/10Timing: Filed June 9, 2026 (transaction dated May 29, 2026).

Background

The article is an SEC Form 4 insider transaction disclosure for Renasant Corp (RNST).

Company-level read

Ticker impact

$RNSTNeutralHigh confidence
Context

Director Connie L Engel filed an open-market sale of 1,257 RNST shares for about $51.4K (Form 4, no 10b5-1 plan).

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

This is a small, disclosed open-market sale by a director with no stated 10b5-1 plan; such prints typically have limited predictive power for price.

Market effects

No sector-level read-through; single-company insider transaction only.

None indicated.

None indicated.

Counterpoint

Even small director sales can reflect near-term liquidity needs or risk management rather than bearish fundamentals; treat as noise unless repeated.

Key entities

  • Renasant Corp

    Company whose director insider sale was disclosed via SEC Form 4.

  • Engel Connie L

    Director who sold 1,257 shares in an open-market transaction.

Related articles

$RNSTMed

Renasant Q2 Earnings Call Highlights

Renasant (NYSE:RNST) management said it expects core margins to stay generally stable in the second half, citing loan maturities of about $1.25B over 12 months at ~4.95% and $50M to $60M monthly securities roll-offs into upper-4% to near-5% yields. The company is not adjusting its outlook for a Fed rate change. Q2 net interest income was $227.7M, non-interest income $51.2M, pre-provision net revenue $112.4M, and it recorded a $3.8M credit-loss provision.

$RNSTMed

RENASANT CORP (RNST): Results of Operations and Financial Condition

RENASANT CORP (RNST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_rnstx2q2026earn.htm EX-99.1 Document Contacts: For Media: For Financials: John S. Oxford James C. Mabry IV Senior Vice President Executive Vice President Chief Marketing Officer Chief Financial Officer (662) 680-1219 (662) 680-1281 RENASANT CORPORATION ANNOUN